Tags: Johnson & Johnson
CVRx gets US $29.6 million funding
The privately held company gets deal with Johnson & Johnson Development Corporation and New Enterprise Associates as co-lead investors.
J&J Engages in US$1 Billion Deal to Boost Prostate Cancer Treatment
Johnson & Johnson announced that it would pay US$1 billion to Aragon Pharmaceuticals and its experimental drugs for prostate cancer treatment.
Elan to sell off itself
Elan Pharmaceuticals has decided to sell itself after the many tendered offers it has received. (Photo : Reuters)The image is the logo of Elan Pharmaceuticals.
